ADMA Biologics, Inc. (NASDAQ:ADMA) is the Best Russell 2000 Stock. On May 6, 2026, ADMA Biologics, Inc. (NASDAQ:ADMA) reported Q1 revenue of $114.5 million, flat YoY. The company delivered adjusted ...
ADMA Biologics Inc. (NASDAQ:ADMA) is one of the best cheap stocks under $10 to buy in June. On May 4, ADMA Biologics received ...
Year-End 2025 Cash Grew to Approximately $88 Million with an Unaudited Operating Cash Flow Estimate of $40 Million in 4Q 2025 2026 Expected to be ADMA's First Full Year of Yield-Enhanced Production, ...
Zacks Investment Research on MSN
ADMA vs Intellia Therapeutics: Which biotech stock is a better pick now?
ADMA Biologics ADMA markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain ...
Q 2026 Total Revenue of $114.5 Million, Flat Year-Over-Year 1Q 2026 ASCENIV Revenue +28% Year-Over-Year; BIVIGAM Revenue -54% Year-Over-Year1Q ...
The MarketWatch News Department was not involved in the creation of this content. Short seller's Characterization of ASCENIV's Competitive Position Reflects Blatant Misunderstanding of ADMA's Business ...
RAMSEY, N.J. and BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company ...
Zacks Investment Research on MSN
New strong sell stocks for June 3rd
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: A. O. Smith Corporation AOS is a residential and commercial gas and electric water utility products company. The Zacks ...
ADMA Biologics ADMA is witnessing a phenomenal run this year. Its shares have skyrocketed 320.6% year to date against the industry’s decline of 7.4%. The stock has also outperformed the sector and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results